EntreMed (ENMD)
EntreMed Debt to Equity Ratio: 3.487
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ENMD Debt to Equity Ratio Rankings
| Overall | 4th percentile | 4082 of 4260 |
| Sector | 3rd percentile | 458 of 477 in Healthcare |
| Industry | 3rd percentile | 141 of 146 in Biotechnology |
ENMD Debt to Equity Ratio Range, Past 5 Years
| Minimum | 0.00 | Mar 2011 |
| Maximum | 8.855 | Mar 2010 |
| Average | 1.862 |
About Debt to Equity Ratio
YCharts Calculation: Debt to Equity = (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity
The debt to equity ratio is a leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. It reveals how a company has financed its assets. A low debt to equity ratio indicates lower risk because shareholder's have claims on a larger portion of the company's assets.
A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.
It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
Learn More
You may also be interested in these ENMD related companies
ENMD News
EntreMed Regains Nasdaq Compliance With Shareholders' Equity Listing Requirement
May 10, 7:01AM Benzinga
May 10, 7:01AM Benzinga
$ENMD forms bearish "Top Triangle" chart pattern. http://stks.co/3fNf
about 25 days ago by RecogniaEvents
about 25 days ago by RecogniaEvents
$ENMD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/338o
about 67 days ago by MarketBrief
about 67 days ago by MarketBrief
$ENMD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/31Yb
about 68 days ago by MarketBrief
about 68 days ago by MarketBrief
EntreMed (ENMD) Enters $9.3M of Strategic Financing, Two Board Members Resign
Feb 06, 7:01AM Street Insider
Feb 06, 7:01AM Street Insider
Biotech Leaders Wei-Wu He, Ph.D and Tak W. Mak, Ph.D Join EntreMed's Board of Directors
Feb 06, 7:00AM PR Newswire
Feb 06, 7:00AM PR Newswire
$ENMD 200 Day SMA Cross - Price crossed above 200 day SMA (2.2611). Confirmed by volume.
about 116 days ago by TradeIdeasQuant
about 116 days ago by TradeIdeasQuant
$ENMD 200 Day SMA Cross - Price crossed above 200 day SMA (2.3135). Confirmed by volume.
about 120 days ago by TradeIdeasQuant
about 120 days ago by TradeIdeasQuant
$ENMD 200 Day SMA Cross - Price crossed below 200 day SMA (2.3135). Confirmed by volume.
about 120 days ago by TradeIdeasQuant
about 120 days ago by TradeIdeasQuant
Small cancer bios hot today. $SNSS starting. $MSHL, $AGEN, $ENMD already went.
about 124 days ago by GarethSoloway
about 124 days ago by GarethSoloway
EntreMed (ENMD) Enters $10M in Purchase Agreements; Will Issue Convertible Notes
Jan 23, 7:04AM Street Insider
Jan 23, 7:04AM Street Insider
Amazing how on a split-adjusted basis the all-time high for $ENMD is over $1000/share. How the mighty have fallen.
about 130 days ago by bradloncar
about 130 days ago by bradloncar
$enmd $spx Been noticing of late that entremed has been up on days that mkt gets killed. No position on $enmd.
about 250 days ago by jerchess
about 250 days ago by jerchess
$ENMD $2.05 OS 11,597,490 amn'd prospectus to offer 107,103 cmn shs (1% dilution) for sale from time to time
about 318 days ago by canarionyc
about 318 days ago by canarionyc
$ENMD $2.60 Mkt Cap $30,105,321 offering $7,500,000 for sale from time to time (25% dilution)
about 335 days ago by canarionyc
about 335 days ago by canarionyc
$VRUS $CYTX $ARIA $ENMD $EXEL A number of biotech companies have new hepatitis C treatments http://equities.com http://stk.ly/ju4LWv $$
about 355 days ago by micstockwell
about 355 days ago by micstockwell
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ENMD | 1.99 | +0.01 | +0.51% | 24.20M |
| ENL | 21.44 | -0.12 | -0.56% | 7.762B |
| ENI | 17.84 | +0.22 | +1.25% | 11.65B |
| ENH | 39.26 | -0.09 | -0.23% | 1.692B |
| ENG | 1.73 | -0.03 | -1.70% | 46.05M |
| ELNK | 8.19 | +0.03 | +0.37% | 869.61M |
| ELN | 14.30 | +1.11 | +8.42% | 8.428B |
| ELLO | 5.65 | -0.20 | -3.42% | 60.91M |
| ELGX | 14.27 | +0.19 | +1.35% | 830.23M |
| EL | 54.96 | -0.13 | -0.24% | 21.31B |
